|
|
Current Issue
|
Alert me when new journal issues are available via  or via  |
|
|
| Neurotherapeutics |
| Volume 7, Issue 3, Pages 229-334 (July 2010) |
|
Search Within This Issue
|
| Treatment in Autism
|
| Edited by Randi J. Hagerman, Robert L. Hendren |
|
|
|
|
|
|
 =free full text
|
|
|
Editorial Board
page i
Full-Text PDF (27 KB)
|
|
Contents
pages ii-iii
Full-Text PDF (44 KB)
|
|
|
Editorials
|
|
Neurotherapeutics to Publish Primary Research Papers
Alan I. Faden, Rohit Bakshi, Michael A. Rogawski
page 229
Full Text |
Full-Text PDF (42 KB)
|
|
Shifting the Paradigm for Autism Treatments
Randi J. Hagerman, Robert L. Hendren
pages 230-231
Full Text |
Full-Text PDF (62 KB)
|
|
|
Review Articles
|
|
Improving the Prediction of Response to Therapy in Autism
Stephen Bent, Robert L. Hendren
pages 232-240
Abstract |
Full Text |
Full-Text PDF (219 KB)
|
|
Tetrahydrobiopterin as a Novel Therapeutic Intervention for Autism
Richard E. Frye, Lynne C. Huffman, Glen R. Elliott
pages 241-249
Abstract |
Full Text |
Full-Text PDF (614 KB)
|
|
Autism and Oxytocin: New Developments in Translational Approaches to Therapeutics
Joshua J. Green, Eric Hollander
pages 250-257
Abstract |
Full Text |
Full-Text PDF (217 KB)
|
|
Aripiprazole in Autism Spectrum Disorders and Fragile X Syndrome
Craig A. Erickson, Kimberly A. Stigler, David J. Posey, Christopher J. McDougle
pages 258-263
Abstract |
Full Text |
Full-Text PDF (164 KB)
|
|
Fragile X: Leading the Way for Targeted Treatments in Autism
Lulu W. Wang, Elizabeth Berry-Kravis, Randi J. Hagerman
pages 264-274
Abstract |
Full Text |
Full-Text PDF (576 KB)
|
|
Targeted Treatments for Cognitive and Neurodevelopmental Disorders in Tuberous Sclerosis Complex
Petrus J. de Vries
pages 275-282
Abstract |
Full Text |
Full-Text PDF (249 KB)
|
|
Immune Dysfunction in Autism: A Pathway to Treatment
Milo Careaga, Judy Van de Water, Paul Ashwood
pages 283-292
Abstract |
Full Text |
Full-Text PDF (439 KB)
|
|
Immune Therapy in Autism: Historical Experience and Future Directions with Immunomodulatory Therapy
Michael G. Chez, Natalie Guido-Estrada
pages 293-301
Abstract |
Full Text |
Full-Text PDF (233 KB)
|
|
Tourette Syndrome: Gene Expression as a Tool to Discover Drug Targets
Isaac H. Liao, Frank R. Sharp
pages 302-306
Abstract |
Full Text |
Full-Text PDF (438 KB)
|
|
Complementary and Alternative Medicine in Autism: An Evidence-Based Approach to Negotiating Safe and Efficacious Interventions with Families
R. Scott Akins, Kathy Angkustsiri, Robin L. Hansen
pages 307-319
Abstract |
Full Text |
Full-Text PDF (444 KB)
|
|
Medical Comorbidities in Autism: Challenges to Diagnosis and Treatment
Margaret L. Bauman
pages 320-327
Abstract |
Full Text |
Full-Text PDF (182 KB)
|
|
|
Abstracts
|
|
Abstract #1: EVP-6124 Elicits Pro-Cognitive Effects in Alzheimer's Patients
Jeffrey T. Apter
page 328
Abstract |
Full-Text PDF (81 KB)
|
|
Abstract #2: Diffusion Tensor Imaging As a Neuroprotection Outcome Metric in Multiple Sclerosis: Clinical Trial Sample Size Estimates
Robert J. Fox, Thomas Cronin, Jian Lin, Ken Sakaie, Daniel Ontaneda, Shamseldeen Y. Mahmoud, Mark J. Lowe, Michael D. Phillips, Xiaofeng Wang
page 328
Abstract |
Full-Text PDF (81 KB)
|
|
Abstract #3: Converting from CIS to Definite Multiple Sclerosis: An Imaging Based Predictive Model
Daniel Goldberg-Zimring, Christian D. Chavarro-Nieto, Brian C. Healy, Anat Achiron, Simon K. Warfield, Mohit Neema, Ashish Arora, Rohit Bakshi
pages 328-329
Abstract |
Full-Text PDF (98 KB)
|
|
Abstract #4: Global vs. Regional Spinal Cord Atrophy in Multiple Sclerosis
Ashish Arora, Mohit Neema, Shahamat Tauhid, Daniel Goldberg-Zimring, Brian C. Healy, James M. Stankiewicz, Christian Chavarro-Nieto, Antonia Ceccarelli, Elisa Dell'Oglio, Charles R.G. Guttmann, Rohit Bakshi
page 329
Abstract |
Full-Text PDF (82 KB)
|
|
Abstract #5: A Phase I, Dosage-Escalation Study of Creatine Monohydrate in Subjects with Amyotrophic Lateral Sclerosis
Nazem Atassi, Eva Maria Ratai, David Greenblatt, Merit Cudkowicz, Allitia DiBernardo
page 329
Abstract |
Full-Text PDF (82 KB)
|
|
Abstract #6: Magnetic Resonance Disease Severity Scale (MRDSS) for Patients with Multiple Sclerosis: A Longitudinal Study
Shahamat S. Tauhid, Jenniffer Moodie, Mohit Neema, Brian C. Healy, Guy J. Buckle, Susan A. Gauthier, Bonnie I. Glanz, Tanuja Chitnis, Samia J. Khoury, Charles R.G. Guttmann, Howard L. Weiner, Rohit Bakshi
pages 329-330
Abstract |
Full-Text PDF (99 KB)
|
|
Abstract #7: Voxel Based Morphometry with DARTEL in Multiple Sclerosis
Antonia Ceccarelli, Jonathan S. Jackson, Ashish Arora, Shahamat S. Tauhid, Christian Chavarro-Nieto, Elisa Dell'Oglio, Daniel Goldberg-Zimring, Anshika Bakshi, Rohit Bakshi, Mohit Neema
page 330
Abstract |
Full-Text PDF (80 KB)
|
|
Abstract #8: Trial Methodology of a Randomized, Double-blind, Parallel-Group Study Evaluating the Clinical Effectiveness of Carisbamate, Topiramate, and Levetiracetam As Adjunctive Treatment of Partial Onset Seizures in Adults
Joyce Cramer, Dennis Dlugos, Frank Wiegand‡, Gerald Novak, William Olson, Augusto Grinspan
pages 330-331
Abstract |
Full-Text PDF (100 KB)
|
|
Abstract #9: Gender Related Outcome Differences after Experimental Mild Traumatic Brain Injury
Shihong Li, David J. Loane, Bogdan A. Stoica, Alan I. Faden
page 331
Abstract |
Full-Text PDF (82 KB)
|
|
Abstract #10: Amyloid Precursor Protein Secretases As Therapeutic Targets for Spinal Cord Injury
Ahdeah Pajoohesh-Ganji, Alan Faden
page 331
Abstract |
Full-Text PDF (82 KB)
|
|
Abstract #11: The Disruptions to Cognition, Everyday Function, and Quality of Life in Oncology Patients: A Therapeutic Opportunity?
Keith Andrew Wesnes, Helen Brooker, Chris Edgar
pages 331-332
Abstract |
Full-Text PDF (99 KB)
|
|
Abstract #12: Computerized Essential Tremor Spirography: Development of a Rater-Independent Outcome Measure for Clinical Trials
Dietrich Haubenberger, Daniel Kalowitz, Fatta B. Nahab, Camilo Toro, Daniel Ippolito, Loretta Wittevrongel, Mark Hallett
page 332
Abstract |
Full-Text PDF (79 KB)
|
|
Abstract #13: Low-Dose Naltrexone's Tolerability and Effects in Fatigued Patients with Parkinson's Disease: An Open-Label Study
Thomas Guttuso, Naomi Salins, David Lichter
page 332
Abstract |
Full-Text PDF (79 KB)
|
|
Abstract #14: Development of a Novel Non-Anxiogenic Broad Spectrum Anti-Emetic
Elaine Alexander, E.H. Pfadenhauer, Charles von Gunten, David Helton
pages 332-333
Abstract |
Full-Text PDF (99 KB)
|
|
Abstract #15: Efficacy and Safety of Long-Acting Injectable Paliperidone Palmitate Relative to Long-Acting Injectable Haloperidol, Bromperidol, and Fluphenazine Decanoate for Long-Term Treatment in Patients with Schizophrenia Using Number Needed to Treat and Number Needed to Harm
Srihari Gopal, Joris Berwaerts, Isaac Nuamah, Kasem Akhras, Danielle Coppola, Ella Daly, David Hough, Joseph Palumbo
page 333
Abstract |
Full-Text PDF (82 KB)
|
|
Abstract #16: Optical Coherence Tomography As a Clinical Trial Outcome Measure in Multiple Sclerosis: Implications of Treating On-Study Relapses with Intravenous Methylprednisolone
Robert Bermel, Peter Imrey, Jeffrey Cohen
page 333
Abstract |
Full-Text PDF (82 KB)
|
|
|
|
|
